Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-008033

Director sold 2,341 shares at $8.49 ($19,878)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-27 Sale : show line 1 in the form −2,341 $8.49 $19,878 20,627 D
Open-market sales · 2,341 sh · avg $8.49 · $19,878
Loading xslF345X04/form4.xml…